Phase II trial of clinical activity and safety of ceritinib combined with stereotactic ablative radiotherapy (SABR) in lung adenocarcinoma patients.

被引：0
|
作者：
Khan, Saad A.
Gerber, David E.
Zhu, Hong
Hughes, Randall S.
Mannala, Samantha
Rashdan, Sawsan
Dowell, Jonathan
Westover, Kenneth D.
Saltarski, Jessica
Harrah, Kasia
Priddy, Laurin
Choy, Hak
Timmerman, Robert D.
Brekken, Rolf A.
Sorrelle, Noah
Iyengar, Puneeth
机构：
[1] Univ Texas Southwestern Med Ctr Dallas, Dallas, TX 75390 USA
[2] Univ Texas Southwestern, Irving, TX USA
[3] Univ Texas Southwestern Med Ctr, Ft Worth, TX USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21571
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Population Based Phase II Trial of Stereotactic Ablative Radiotherapy (SABR): Overall Survival Results of the SABR-5 Trial
    Jiang, W. N.
    Baker, S.
    Liu, M.
    Bergman, A.
    Schellenberg, D.
    Mou, B.
    Alexander, A. S.
    Carolan, H.
    Atrchian, S.
    Chan, E. K.
    Mohamed, I. G.
    Berrang, T.
    Bang, A.
    Chng, N.
    Matthews, Q.
    Pai, H. H.
    Lefresne, S.
    Tyldesley, S.
    Olson, R. A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2022, 114 (03): : S147 - S148
  • [2] Safety of Pembrolizumab Combined with Stereotactic Ablative Body Radiotherapy (SABR) for Pulmonary Oligometastases
    Siva, S.
    Bressel, M.
    Loi, S.
    Sandhu, S.
    Tran, B.
    Mooi, J.
    Lewin, J.
    Azad, A.
    Colyer, D.
    Shaw, M.
    Chander, S.
    Cuff, K.
    Wood, S.
    Lawrentschuk, N.
    Murphy, D.
    Pryor, D.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S248 - S248
  • [3] Efficacy and safety profile of Stereotactic Ablative Radiotherapy (SABR) for multiple lung primaries
    Littlejohns, A.
    Janjua, T.
    Murray, P.
    Jain, P.
    Clarke, K.
    Dickinson, P.
    Teo, M.
    Saha, A.
    Franks, K.
    Sun, F.
    RADIOTHERAPY AND ONCOLOGY, 2020, 152 : S542 - S542
  • [4] Stereotactic Ablative Radiotherapy For Lung Cancer In Elderly Patients.
    Revelant, A.
    Emilio, M.
    Marco, T.
    Antonino, D. P.
    Carlo, G.
    Giuseppe, F.
    Elisa, P.
    Fabio, M.
    Federico, N.
    Umberto, Z.
    Jerry, P.
    Giovanni, F.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S744 - S745
  • [5] Clinical implementation of stereotactic ablative radiotherapy (SABR) for lung early stage NSCLC
    Routsis, D.
    Dean, J.
    Archer, S.
    Ferriera, C.
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S304 - S304
  • [6] A Phase II Trial of Individualized Stereotactic Ablative Radiotherapy for Lung Tumors (iSABR)
    Gensheimer, M. F.
    Gee, H. E.
    Von Eyben, R.
    Shirato, H.
    Taguchi, H.
    Wong, S.
    Brown, E.
    Nguyen, N.
    Liang, R.
    Maxim, P. G.
    Wakelee, H. A.
    Neal, J. W.
    Das, M.
    Loo, B. W., Jr.
    Diehn, M.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : S89 - S90
  • [7] Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
    Robert Olson
    Mitchell Liu
    Alanah Bergman
    Sonya Lam
    Fred Hsu
    Benjamin Mou
    Tanya Berrang
    Ante Mestrovic
    Nick Chng
    Derek Hyde
    Quinn Matthews
    Chad Lund
    Daniel Glick
    Howard Pai
    Parminder Basran
    Hannah Carolan
    Boris Valev
    Shilo Lefresene
    Scott Tyldesley
    Devin Schellenberg
    BMC Cancer, 18
  • [8] Population-based phase II trial of stereotactic ablative radiotherapy (SABR) for up to 5 oligometastases: SABR-5
    Olson, Robert
    Liu, Mitchell
    Bergman, Alanah
    Lam, Sonya
    Hsu, Fred
    Mou, Benjamin
    Berrang, Tanya
    Mestrovic, Ante
    Chng, Nick
    Hyde, Derek
    Matthews, Quinn
    Lund, Chad
    Glick, Daniel
    Pai, Howard
    Basran, Parminder
    Carolan, Hannah
    Valev, Boris
    Lefresene, Shilo
    Tyldesley, Scott
    Schellenberg, Devin
    BMC CANCER, 2018, 18
  • [9] Phase II Clinical Trial of Stereotactic Ablative Radiotherapy (SABR) in Surgically Operable Stage I Non-Small Cell Lung Cancer (STARS)
    Chang, Joe Y.
    Mehran, Reza
    Balter, Peter
    Mcrae, Stephen
    Feng, Lei
    Berry, Donald
    Komaki, Ritsuko U.
    Roth, Jack
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S563 - S563
  • [10] Safety and Efficacy of Stereotactic Ablative Radiotherapy (SABR) to Multiple (3 or More) Lung Tumors
    Moding, E. J.
    Maxim, P. G.
    Diehn, M.
    Loo, B. W., Jr.
    Gensheimer, M. F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (02): : E482 - E482
12345